The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Bacterial co‐infections with SARS‐CoV‐2
Open accessAbstract
The pandemic coronavirus disease 2019 (COVID‐19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), has affected millions of people worldwide. To date, there are no proven effective therapies for this virus. Efforts made to develop antiviral strategies for the treatment of COVID‐19 are underway. Respiratory viral infections, such as influenza, predispose patients to co‐infections and these lead to increased disease severity and mortality. Numerous types of antibiotics such as azithromycin have been employed for the prevention and treatment of bacterial co‐infection and secondary bacterial infections in patients with a viral respiratory infection (e.g., SARS‐CoV‐2). Although antibiotics do not directly affect SARS‐CoV‐2, viral respiratory infections often result in bacterial pneumonia. It is possible that some patients die from bacterial co‐infection rather than virus itself. To date, a considerable number of bacterial strains have been resistant to various antibiotics such as azithromycin, and the overuse could render those or other antibiotics even less effective. Therefore, bacterial co‐infection and secondary bacterial infection are considered critical risk factors for the severity and mortality rates of COVID‐19. Also, the antibiotic‐resistant as a result of overusing must be considered. In this review, we will summarize the bacterial co‐infection and secondary bacterial infection in some featured respiratory viral infections, especially COVID‐19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa530 · Cited by 1,662
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · cited 1×
“The oldest report of bacterial infections that occurred simultaneously or shortly after influenza is related to the 1918 Influenza pandemic, in which most deaths occurred as a result of co-infection with infectious bacteria.(35) Also, the H1N1 Influenza pandemic in 2009 was complicated by bacterial pneumonia in 4–33%…”
BackgroundCloning of a human parvovirus by molecular screening of respiratory tract samples
Allander, T., Tammi, M. T., Eriksson, M., Bjerkner, A., Tiveljung-Lindell, A., & Andersson, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504666102 · Cited by 1,580
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Phua, J., Weng, L., Ling, L., Egi, M., Lim, C.-M., Divatia, J. V., Shrestha, B. R., Arabi, Y. M., Ng, J., Gomersall, C. D., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30161-2 · Cited by 1,509
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know
Rasmussen, S. A., Smulian, J. C., Lednicky, J. A., Wen, T. S., & Jamieson, D. J. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.02.017 · Cited by 1,247
The drug-resistant bacteria that pose the greatest health threats
Willyard, C. (2017) · Nature · doi:10.1038/nature.2017.21550 · Cited by 1,221
Zimmermann, P., & Curtis, N. (2020) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002660 · Cited by 1,077
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908481 · Cited by 1,001
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., Wang, X., Hu, C., Ping, R., Hu, P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0543oc · Cited by 942
Biofilm infections, their resilience to therapy and innovative treatment strategies
Römling, U., & Balsalobre, C. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12004 · Cited by 865
Yu, N., Li, W., Kang, Q., Xiong, Z., Wang, S., Lin, X., Liu, Y., Xiao, J., Liu, H., Deng, D., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30176-6 · Cited by 858
Insights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
Tuberculosis and HIV Co-Infection
Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., & Källenius, G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002464 · Cited by 764
The co-pathogenesis of influenza viruses with bacteria in the lung.
McCullers, J. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3231 · Cited by 722 · cited 2×
“These detrimental changes include altered mucus secretion, cell death, hyperplasia, decreased mucosal clearance, reduced oxygen exchange, and impaired surfactant secretion.(42,77) Each of these effects is caused by various molecular mechanisms, depending on the virus, bacterial species, as well as the degree of the ho…”
BackgroundClinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
Gao, H.-N., Lu, H.-Z., Cao, B., Du, B., Shang, H., Gan, J.-H., Lu, S.-H., Yang, Y.-D., Fang, Q., Shen, Y.-Z., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305584 · Cited by 651
Nikolich-Zugich, J., Knox, K. S., Rios, C. T., Natt, B., Bhattacharya, D., & Fain, M. J. (2020) · GeroScience · doi:10.1007/s11357-020-00186-0 · Cited by 577
Secondary bacterial infections associated with influenza pandemics
Morris, D. E., Cleary, D. W., & Clarke, S. C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01041 · Cited by 576
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Hagan, T., Cortese, M., Rouphael, N., Boudreau, C., Linde, C., Maddur, M. S., Das, J., Wang, H., Guthmiller, J., Zheng, N.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.010 · Cited by 572
Conenello, G. M., Zamarin, D., Perrone, L. A., Tumpey, T., & Palese, P. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030141 · Cited by 514
Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia.
Hanada, S., Pirzadeh, M., Carver, K. Y., & Deng, J. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02640 · Cited by 495
Singh, A. K., Singh, A., Shaikh, A., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.011 · Cited by 488
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479
Treatment of SARS with human interferons
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13973-6 · Cited by 467
Complications of Viral Influenza
Rothberg, M. B., Haessler, S. D., & Brown, R. B. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.10.040 · Cited by 456 · cited 1×
“The mortality rate seems to be still growing mostly because of the rapid rate of aging in the human population.(41,42) Although viruses are commonly responsible for the development of acute upper and lower respiratory infections, in most cases patients may be infected by both bacterial and viral pathogens; however, th…”
BackgroundIs COVID-19 receiving ADE from other coronaviruses?
Tetro, J. A. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.006 · Cited by 434
Narayanan, K., Huang, C., Lokugamage, K., Kamitani, W., Ikegami, T., Tseng, C.-T. K., & Makino, S. (2008) · Journal of Virology · doi:10.1128/jvi.02472-07 · Cited by 427
Zhang, B., Liu, S., Tan, T., Huang, W., Dong, Y., Chen, L., Chen, Q., Zhang, L., Zhong, Q., Zhang, X., et al. (2020) · Chest · doi:10.1016/j.chest.2020.03.039 · Cited by 420
Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411
El Zowalaty, M. E., & Järhult, J. D. (2020) · One Health · doi:10.1016/j.onehlt.2020.100124 · Cited by 405
Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections
Ghoneim, H. E., Thomas, P. G., & McCullers, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300014 · Cited by 394
Rice, T. W., Rubinson, L., Uyeki, T. M., Vaughn, F. L., John, B. B., Miller, R. R., Higgs, E., Randolph, A. G., Smoot, B. E., & Thompson, B. T. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182416f23 · Cited by 391
Role of Neuraminidase in Lethal Synergism between Influenza Virus and Streptococcus pneumoniae
McCullers, J. A., & Bartmess, K. C. (2003) · The Journal of Infectious Diseases · doi:10.1086/368163 · Cited by 386
Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques
Haagmans, B. L., Kuiken, T., Martina, B. E., Fouchier, R. A. M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., de Jong, T., Itamura, S., Chan, K.-H., et al. (2004) · Nature Medicine · doi:10.1038/nm1001 · Cited by 381
Co-infections: potentially lethal and unexplored in COVID-19
Cox, M. J., Loman, N., Bogaert, D., & O'Grady, J. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30009-4 · Cited by 381
Regulating the adaptive immune response to respiratory virus infection
Braciale, T. J., Sun, J., & Kim, T. S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3166 · Cited by 361
Avadhanula, V., Rodriguez, C. A., DeVincenzo, J. P., Wang, Y., Webby, R. J., Ulett, G. C., & Adderson, E. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1629-1636.2006 · Cited by 357 · cited 1×
“Such differences are determined by the types of epithelial cells and their response to parainfluenza virus-3, respiratory syncytial virus, and/or influenza virus.(83) Novotny et al(84) showed that adenovirus and respiratory MIRZAEI ET AL.”
BackgroundMacIntyre, C. R., Chughtai, A. A., Barnes, M., Ridda, I., Seale, H., Toms, R., & Heywood, A. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3548-0 · Cited by 323
Finelli, L., Fiore, A., Dhara, R., Brammer, L., Shay, D. K., Kamimoto, L., Fry, A., Hageman, J., Gorwitz, R., Bresee, J., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1336 · Cited by 312
Wang, K., Zuo, P., Liu, Y., Zhang, M., Zhao, X., Xie, S., Zhang, H., Chen, X., & Liu, C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa538 · Cited by 288
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease
Rynda-Apple, A., Robinson, K. M., & Alcorn, J. F. (2015) · Infection and Immunity · doi:10.1128/iai.00298-15 · Cited by 286
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
Ritchie, A. I., & Singanayagam, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30691-7 · Cited by 283
Nakamura, S., Davis, K. M., & Weiser, J. N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57762 · Cited by 280
Spiegel, M., Pichlmair, A., Martínez-Sobrido, L., Cros, J., García-Sastre, A., Haller, O., & Weber, F. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2079-2086.2005 · Cited by 279
Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza
Palacios, G., Hornig, M., Cisterna, D., Savji, N., Bussetti, A. V., Kapoor, V., Hui, J., Tokarz, R., Briese, T., Baumeister, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008540 · Cited by 275
Role of Staphylococcus protease in the development of influenza pneumonia
Tashiro, M., Ciborowski, P., Klenk, H.-D., Pulverer, G., & Rott, R. (1987) · Nature · doi:10.1038/325536a0 · Cited by 273
Siegel, S. J., Roche, A. M., & Weiser, J. N. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.06.005 · Cited by 247
Teicoplanin: an alternative drug for the treatment of COVID-19?
Baron, S. A., Devaux, C., Colson, P., Raoult, D., & Rolain, J.-M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105944 · Cited by 243
The 2009 H1N1 influenza outbreak in its historical context.
Gatherer, D. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.06.004 · Cited by 227
SARS ‐CoV‐2, bacterial co‐infections, and AMR : the deadly trio in COVID ‐19?
Bengoechea, J. A., & Bamford, C. G. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012560 · Cited by 222
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
Peltola, V. T., Murti, K. G., & McCullers, J. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/430954 · Cited by 219
Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease
Chao, Y., Marks, L. R., Pettigrew, M. M., & Hakansson, A. P. (2015) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00194 · Cited by 213
Viral–bacterial co-infections in the respiratory tract
Bakaletz, L. O. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.11.003 · Cited by 205
Immune Dysfunction and Bacterial Coinfections following Influenza
Metzger, D. W., & Sun, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301152 · Cited by 199
Viral and Atypical Bacterial Detection in Acute Respiratory Infection in Children Under Five Years
Bezerra, P. G. M., Britto, M. C. A., Correia, J. B., Duarte, M. D. C. M. B., Fonceca, A. M., Rose, K., Hopkins, M. J., Cuevas, L. E., & McNamara, P. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018928 · Cited by 198
Kinetics of Coinfection with Influenza A Virus and Streptococcus pneumoniae
Smith, A. M., Adler, F. R., Ribeiro, R. M., Gutenkunst, R. N., McAuley, J. L., McCullers, J. A., & Perelson, A. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003238 · Cited by 196
Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections
Davidson, S., Maini, M. K., & Wack, A. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0227 · Cited by 196
A Simultaneous Outbreak of Meningococcal and Influenza Infections
Young, L. S., LaForce, F. M., Head, J. J., Feeley, J. C., & Bennett, J. V. (1972) · New England Journal of Medicine · doi:10.1056/nejm197207062870102 · Cited by 192
Wolter, N., Tempia, S., Cohen, C., Madhi, S. A., Venter, M., Moyes, J., Walaza, S., Malope-Kgokong, B., Groome, M., du Plessis, M., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu326 · Cited by 186
Human Coronavirus NL63 and 229E Seroconversion in Children
Dijkman, R., Jebbink, M. F., El Idrissi, N. B., Pyrc, K., Müller, M. A., Kuijpers, T. W., Zaaijer, H. L., & van der Hoek, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00533-08 · Cited by 185
PETERSEN, N. T., HØIBY, N., MORDHORST, C. H., LIND, K., FLENSBORG, E. W., & BRUUN, B. (1981) · Acta Paediatrica · doi:10.1111/j.1651-2227.1981.tb05757.x · Cited by 184
How do viral infections predispose patients to bacterial infections?
Beadling, C., & Slifka, M. K. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200406000-00003 · Cited by 183
Doern, G. V., Jones, R. N., Pfaller, M. A., Kugler, K., & The Sentry Participants Group (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.385 · Cited by 178
Ramphal, R., Small, P. M., Shands, J. W., Fischlschweiger, W., & Small, P. A. (1980) · Infection and Immunity · doi:10.1128/iai.27.2.614-619.1980 · Cited by 171
Influenza virus primes mice for pneumonia from Staphylococcus aureus.
Iverson, A. R., Boyd, K. L., McAuley, J. L., Plano, L. R., Hart, M. E., & McCullers, J. A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq113 · Cited by 168
Hendricks, M. R., Lashua, L. P., Fischer, D. K., Flitter, B. A., Eichinger, K. M., Durbin, J. E., Sarkar, S. N., Coyne, C. B., Empey, K. M., & Bomberger, J. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516979113 · Cited by 168
Direct interactions with influenza promote bacterial adherence during respiratory infections
Rowe, H. M., Meliopoulos, V. A., Iverson, A., Bomme, P., Schultz-Cherry, S., & Rosch, J. W. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0447-0 · Cited by 161
Nutritional Immunity: Starving Pathogens of Trace Minerals
Hennigar, S. R., & McClung, J. P. (2016) · American Journal of Lifestyle Medicine · doi:10.1177/1559827616629117 · Cited by 158
Wu, F., Su, Z., Yu, B., Chen, Y., Wang, W., Hu, Y., Song, Z., Tao, Z., Tian, J.-H., Pei, Y.-Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.24.919183 · Cited by 156
Serisier, D. J. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70038-9 · Cited by 149
Yap, F. H. Y., Gomersall, C. D., Fung, K. S. C., Ho, P., Ho, O. M., Lam, P. K. N., Lam, D., Lyon, D. J., & Joynt, G. M. (2004) · Clinical Infectious Diseases · doi:10.1086/422641 · Cited by 148
Li, N., Ren, A., Wang, X., Fan, X., Zhao, Y. X., Gao, G. F., Cleary, P. P., & Wang, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414422112 · Cited by 145
Bordi, L., Nicastri, E., Scorzolini, L., Di, A., Capobianchi, M. R., Castilletti, C., & Lalle, E. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.8.2000170 · Cited by 145
Krähling, V., Stein, D. A., Spiegel, M., Weber, F., & Mühlberger, E. (2008) · Journal of Virology · doi:10.1128/jvi.01245-08 · Cited by 143
Secondary Bacterial Infections in Influenza Virus Infection Pathogenesis
Smith, A. M., & McCullers, J. A. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_394 · Cited by 143
Virus-Bacteria Interactions: An Emerging Topic in Human Infection
Almand, E. A., Moore, M. D., & Jaykus, L. (2017) · Viruses · doi:10.3390/v9030058 · Cited by 137
Lee, B., Robinson, K. M., McHugh, K. J., Scheller, E. V., Mandalapu, S., Chen, C., Di, Y. P., Clay, M. E., Enelow, R. I., Dubin, P. J., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00338.2014 · Cited by 135
Jia, L., Xie, J., Zhao, J., Cao, D., Liang, Y., Hou, X., Wang, L., & Li, Z. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00338 · Cited by 135
The immunology of influenza virus-associated bacterial pneumonia.
Robinson, K. M., Kolls, J. K., & Alcorn, J. F. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.002 · Cited by 132
Robinson, K. M., McHugh, K. J., Mandalapu, S., Clay, M. E., Lee, B., Scheller, E. V., Enelow, R. I., Chan, Y. R., Kolls, J. K., & Alcorn, J. F. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit527 · Cited by 131
Sun, K., & Metzger, D. W. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303049 · Cited by 130
IMMATURE CIRCULATING NEUTROPHILS IN SEPSIS HAVE IMPAIRED PHAGOCYTOSIS AND CALCIUM SIGNALING
Taneja, R., Sharma, A. P., Hallett, M. B., Findlay, G. P., & Morris, M. R. (2008) · Shock · doi:10.1097/shk.0b013e318173ef9c · Cited by 126
IMPORTANCE OF STAPHYLOCOCCUS AUREUS IN PNEUMONIA IN THE 1957 EPIDEMIC OF INFLUENZA A
Robertson, L., Caley, J. P., & Moore, J. (1958) · The Lancet · doi:10.1016/s0140-6736(58)90060-6 · Cited by 123
Covid-19 induced superimposed bacterial infection
Hendaus, M. A., & Jomha, F. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772110 · Cited by 123
Macrolides in critically ill patients with Middle East Respiratory Syndrome
Arabi, Y. M., Deeb, A., Al-Hameed, F. M., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.01.041 · Cited by 122
Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation
Frieman, M. B., & Baric, R. S. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-08 · Cited by 117
McArdle, A. J., Turkova, A., & Cunnington, A. J. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000447 · Cited by 117
RSV Mediates Pseudomonas aeruginosa Binding to Cystic Fibrosis and Normal Epithelial Cells
van Ewijk, B. E., Wolfs, T. F. W., Aerts, P. C., Van Kessel, K. P. M., Fleer, A., Kimpen, J. L. L., & Van Der Ent, C. K. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180332d1c · Cited by 113
Bacterial adherence to virus-infected cells: a cell culture model of bacterial superinfection.
Sanford, B. A., Shelokov, A., & Ramsay, M. A. (1978) · Journal of Infectious Diseases · doi:10.1093/infdis/137.2.176 · Cited by 111
Hament, J.-M., Aerts, P. C., Fleer, A., van Dijk, H., Harmsen, T., Kimpen, J. L. L., & Wolfs, T. F. W. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000127431.11750.d9 · Cited by 111
di Mauro, G., Scavone, C., Rafaniello, C., Rossi, F., & Capuano, A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106519 · Cited by 111
Pettigrew, M. M., Marks, L. R., Kong, Y., Gent, J. F., Roche-Hakansson, H., & Hakansson, A. P. (2014) · Infection and Immunity · doi:10.1128/iai.02225-14 · Cited by 110
Postinfluenza bacterial pneumonia: Host defenses gone awry
Ballinger, M. N., & Standiford, T. J. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0049 · Cited by 103
Freundt, E. C., Yu, L., Park, E., Lenardo, M. J., & Xu, X. (2009) · Journal of Virology · doi:10.1128/jvi.00367-09 · Cited by 103
Molecular Biology of the SARS-Coronavirus
Lal, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-642-03683-5 · Cited by 103
First COVID-19 infections in the Philippines: a case report
Edrada, E. M., Lopez, E. B., Villarama, J. B., Villarama, E. P. S., Dagoc, B. F., Smith, C. E., Sayo, A. R., Verona, J. A., Trifalgar-Arches, J., Lazaro, J., et al. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00203-0 · Cited by 98
Bacterial sinusitis and otitis media following influenza virus infection in ferrets
Peltola, V. T., Boyd, K. L., McAuley, J. L., Rehg, J. E., & McCullers, J. A. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2562-2567.2006 · Cited by 95
Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
Cillóniz, C., Ewig, S., Menéndez, R., Ferrer, M., Polverino, E., Reyes, S., Gabarrús, A., Marcos, M. A., Cordoba, J., Mensa, J., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.04.009 · Cited by 94
Chattoraj, S. S., Ganesan, S., Jones, A. M., Helm, J. M., Comstock, A. T., Bright-Thomas, R. J., LiPuma, J. J., Hershenson, M. B., & Sajjan, U. S. (2011) · Thorax · doi:10.1136/thx.2010.151431 · Cited by 93
Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells
Paget, C., & Trottein, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00336 · Cited by 91
JANSEN, A. G. S. C., SANDERS, E. A. M., VAN DER ENDE, A., VAN LOON, A. M., HOES, A. W., & HAK, E. (2008) · Epidemiology and Infection · doi:10.1017/s0950268807000271 · Cited by 85
Staphylococcus aureus and Influenza A Virus: Partners in Coinfection
Mulcahy, M. E., & McLoughlin, R. M. (2016) · mBio · doi:10.1128/mbio.02068-16 · Cited by 83
Viral-Bacterial Synergistic Interaction in Respiratory Disease
Babiuk, L. A., Lawman, M. J., & Bielefeldt‐Ohmann, H. (1988) · Advances in virus research · doi:10.1016/s0065-3527(08)60713-7 · Cited by 80
McGillivary, G., Mason, K. M., Jurcisek, J. A., Peeples, M. E., & Bakaletz, L. O. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01339.x · Cited by 79
Wolf, D. G., Greenberg, D., Shemer‐Avni, Y., Givon‐Lavi, N., Bar‐Ziv, J., & Dagan, R. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.07.014 · Cited by 79
HUMAN CORONAVIRUS NL63 ASSOCIATED WITH LOWER RESPIRATORY TRACT SYMPTOMS IN EARLY LIFE
Kaiser, L., Regamey, N., Roiha, H. L., et al. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000183773.80217.12 · Cited by 77
Panton-Valentine Leukocidin–Secreting Staphylococcus aureus Pneumonia Complicating COVID-19
Duployez, C., Guern, R. L., Tinez, C., Lejeune, A.-L., Robriquet, L., Six, S., Loïez, C., & Wallet, F. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.201413 · Cited by 77
Johansson, N., Kalin, M., & Hedlund, J. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.570785 · Cited by 75
MacIntyre, C. R., & Bui, C. M. (2017) · Archives of Public Health · doi:10.1186/s13690-017-0223-7 · Cited by 75
Zahariadis, G., Gooley, T. A., Ryall, P., Hutchinson, C., Latchford, M., Fearon, M. A., Jamieson, F., Richardson, S. E., Kuschak, T. I., & Mederski, B. (2006) · Canadian Respiratory Journal · doi:10.1155/2006/862797 · Cited by 74
Infection With Community-Onset Staphylococcus aureus and Influenza Virus in Hospitalized Children
Reed, C., Kallen, A. J., Patton, M., Arnold, K. E., Farley, M. M., Hageman, J., & Finelli, L. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819d8b71 · Cited by 72
Impact of microbial Aetiology on mortality in severe community-acquired pneumonia
Quah, J., Jiang, B., Tan, P. C., Siau, C., & Tan, T. Y. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3366-4 · Cited by 71
Alfaraj, S. H., Al‐Tawfiq, J. A., Altuwaijri, T. A., & Memish, Z. A. (2017) · Intervirology · doi:10.1159/000477908 · Cited by 68
Neutrophils in community-acquired pneumonia: parallels in dysfunction at the extremes of age
Grudzinska, F. S., Brodlie, M., Scholefield, B. R., Jackson, T., Scott, A., THICKETT, D. R., & Sapey, E. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212826 · Cited by 68
Blasco, M. L., Buesa, J., Colomina, J., Forner, M. J., Galindo, M. J., Navarro, J., Noceda, J., Redón, J., Signes‐Costa, J., & Navarro, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25922 · Cited by 66
Co-infection subverts mucosal immunity in the upper respiratory tract
Lijek, R. S., & Weiser, J. N. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.05.005 · Cited by 65
S, &. K. (1962) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196209000-00062 · Cited by 64
Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations
Abdel-Moneim, A. S. (2014) · Archives of Virology · doi:10.1007/s00705-014-1995-5 · Cited by 62
Viral-bacterial co-infection in Australian Indigenous children with acute otitis media
Binks, M., Cheng, A. C., Smith‐Vaughan, H., Sloots, T. P., Nissen, M. D., Whiley, D. M., McDonnell, J., & Leach, A. J. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-161 · Cited by 59
The Association of Meningococcal Disease with Influenza in the United States, 1989–2009
Jacobs, J. H., Viboud, C. G., Tchetgen, E. T., Schwartz, J. D., Steiner, C., Simonsen, L., & Lipsitch, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107486 · Cited by 59
on behalf of the Adult Pneumonia Study Group-Japan, Katsurada, N., Suzuki, M., Aoshima, M., Yaegashi, M., Ishifuji, T., Asoh, N., Hamashige, N., Abe, M., Ariyoshi, K., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2858-y · Cited by 56
Crotty, M. P., Meyers, S., Hampton, N. B., Bledsoe, S., Ritchie, D. J., Buller, R. S., Storch, G. A., Micek, S. T., & Kollef, M. H. (2015) · Medicine · doi:10.1097/md.0000000000002332 · Cited by 55
Kleinerman, E. S., Daniels, C. A., Polisson, R. P., & D, R. S. M. (1976) · PubMed Central · Cited by 53
Why is coinfection with influenza virus and bacteria so difficult to control?
Cauley, L. S., & Vella, A. T. (2015) · PubMed · Cited by 53
Infection with human coronavirus NL63 enhances streptococcal adherence to epithelial cells
Gołda, A., Małek, N., Dudek, B., Żegleń, S., Wojarski, J., Ochman, M., Kucewicz-Czech, E. M., Zembala, M., Potempa, J., & Pyrć, K. (2011) · Journal of General Virology · doi:10.1099/vir.0.028381-0 · Cited by 50
Burden of disease due to human coronavirus NL63 infections and periodicity of infection
van der Hoek, L., Ihorst, G., Sure, K., Vabret, A., Dijkman, R., de Vries, M., Förster, J., Berkhout, B., & Überla, K. (2010) · Journal of Clinical Virology · doi:10.1016/j.jcv.2010.02.023 · Cited by 49
Sun, K., Yajjala, V. K., Bauer, C. D., Talmon, G. A., Fischer, K. J., Kielian, T., & Metzger, D. W. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20150514 · Cited by 49
Novotny, L. A., & Bakaletz, L. O. (2016) · Cellular Microbiology · doi:10.1111/cmi.12575 · Cited by 48
The potential impact of coinfection on antimicrobial chemotherapy and drug resistance
Birger, R. B., Kouyos, R. D., Cohen, T., Griffiths, E. C., Huijben, S., Mina, M. J., Volkova, V. V., Grenfell, B. T., & Metcalf, C. J. E. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.05.002 · Cited by 46
Ciencewicki, J., Gowdy, K. M., Krantz, Q. T., Linak, W. P., Brighton, L. E., Gilmour, M. I., & Jaspers, I. (2007) · Inhalation Toxicology · doi:10.1080/08958370701665426 · Cited by 43
Melvin, J. A., & Bomberger, J. M. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005797 · Cited by 41
Esposito, S., Zampiero, A., Terranova, L., Ierardi, V., Ascolese, B., Daleno, C., Prada, E., Pelucchi, C., & Principi, N. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31829ec274 · Cited by 39
Bacterial Involvement in Parainfluenza Virus Infection in Children
Korppi, M. O., Leinonen, M., Mäkelä, P. H., & LAUNIALA, K. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009027052 · Cited by 38
The Role of Virus Infection in Deregulating the Cytokine Response to Secondary Bacterial Infection
Mehta, D., Petes, C., Gee, K., & Basta, S. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0072 · Cited by 37
Influenza and Bacterial Pathogen Coinfections in the 20th Century
Wang, X.-Y., Kilgore, P. E., Lim, K. A., Wang, S.-M., Lee, J., Deng, W., Mo, M.-Q., Nyambat, B., Ma, J.-C., Favorov, M. O., et al. (2011) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2011/146376 · Cited by 37
Alterations in Lung Macrophage Antimicrobial Activity Associated with Viral Pneumonia
Warr, G. A., & Jakab, G. J. (1979) · Infection and Immunity · doi:10.1128/iai.26.2.492-497.1979 · Cited by 37
Alterations in lung macrophage immune receptor(s) activity associated with viral pneumonia.
Warr, G. A., Jakab, G. J., & Je, H. (1979) · PubMed · Cited by 37
Su, I.-C., Lee, K., Liu, H.-Y., Chuang, H.-C., Chen, L., & Lee, Y. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.05.007 · Cited by 33
Respiratory Viruses and Atypical Bacteria Co-Infection in Children with Acute Respiratory Infection
Baroudy, N. R. E., Refay, A. S. E., Hamid, T. A. A., Hassan, D. M., Soliman, M. S., & Sherif, L. S. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.332 · Cited by 33
Molecular Diagnosis of TB in the HIV Positive Population
Vittor, A. Y., Garland, J. M., & Gilman, R. H. (2015) · Annals of Global Health · doi:10.1016/j.aogh.2015.01.001 · Cited by 28
Mina, M. J., Burke, R. M., & Klugman, K. P. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2120-0 · Cited by 25
Kongchanagul, A., Suptawiwat, O., Boonarkart, C., Kitphati, R., Puthavathana, P., Uiprasertkul, M., & Auewarakul, P. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22105 · Cited by 22
Tong, J., Fu, Y., Meng, F., Krüger, N., Valentin‐Weigand, P., & Herrler, G. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00280 · Cited by 20
A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients
Soltani, S., Zakeri, A., Tabibzadeh, A., Zandi, M., Ershadi, E., Rezayat, S. A., Khaseb, S., Zakeri, A. M., Nakhaei, M. A., Afzali, S., et al. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00284-x · Cited by 20
Epidemiology of Human Immunodeficiency Virus–Associated Pulmonary Disease
Murray, J. F. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.02.004 · Cited by 19
Cooperation between Viral and Bacterial Pathogens in Causing Human Respiratory Disease
Smith, H. C., & Sweet, C. (2014) · ASM Press eBooks · doi:10.1128/9781555817947.ch11 · Cited by 13
Role of Autophagy and Apoptosis in the Postinfluenza Bacterial Pneumonia
Qin, Z., Yang, Y., Wang, H., Luo, J., Huang, X., You, J., Wang, B., & Li, M. (2016) · BioMed Research International · doi:10.1155/2016/3801026 · Cited by 13
Influenza and Staphylococcus aureus Coinfection: TLR9 at Play
Sun, K., & Metzger, D. W. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.02.006 · Cited by 12
Sepsis and Pleural Empyema Caused by Streptococcus pyogenes after Influenza A Virus Infection
Ochi, F., Tauchi, H., Jogamoto, T., Miura, H., Moritani, T., Nagai, K., & Ishii, E. (2018) · Case Reports in Pediatrics · doi:10.1155/2018/4509847 · Cited by 10
Wang, J. B., Xu, N., Shi, H. Z., Huang, X. Z., & Lin, L. (2003) · PubMed · Cited by 4
Antibiotics blunt flu immunity
Kelly, P. N. (2019) · Science · doi:10.1126/science.366.6462.197-f · Cited by 1
Cited by
Antimicrobial Susceptibility Testing: A Comprehensive Review of Currently Used Methods
Gajic, I., Kabic, J., Kekic, D., Jovicevic, M., Milenkovic, M., Mitic Culafic, D., Trudic, A., Ranin, L., & Opavski, N. (2022) · Antibiotics · doi:10.3390/antibiotics11040427 · Cited by 557
The role of co-infections and secondary infections in patients with COVID-19
Feldman, C., & Anderson, R. (2021) · Pneumonia · doi:10.1186/s41479-021-00083-w · Cited by 319
Mohapatra, S., Yutao, L., Goh, S. G., Ng, C., Luhua, Y., Tran, N. H., & Gin, K. Y.-H. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.130393 · Cited by 268
Graphitic carbon nitride-based materials for photocatalytic antibacterial application
Kong, X., Liu, X., Zheng, Y., Chu, P. K., Zhang, Y., & Wu, S. (2021) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2021.100610 · Cited by 259
Metadata
- Authors
- Mirzaei, R., Goodarzi, P., Asadi, M., Soltani, A., Aljanabi, H. A. A., Jeda, A. S., Dashtbin, S., Jalalifar, S., Mohammadzadeh, R., Teimoori, A., Tari, K., Salari, M., Ghiasvand, S., Kazemi, S., Yousefimashouf, R., Keyvani, H., & Karampoor, S.
- Venue
- IUBMB Life
- Publisher
- Wiley
- Published
- 2020-08-08
- Volume
- 72
- Issue
- 10
- Pages
- 2097-2111
- ISSN
- 1521-6543 (ISSN-L)
- 1521-6551
- OpenAlex
- W3048203659
- Cited by
- 291
- References
- 161
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.